e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
COPD: new markers of diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Myofibroblast expression in airways and alveoli is affected by smoking and COPD
H. Karvonen, S. Lehtonen, T. Harju, R. Sormunen, E. Lappi-Blanco, J. Mäkinen, K. Laitakari, S. Johnson, R. Kaarteenaho (Oulu, Kuopio, Finland)
Source:
Annual Congress 2013 –COPD: new markers of diseases
Session:
COPD: new markers of diseases
Session type:
Thematic Poster Session
Number:
609
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Karvonen, S. Lehtonen, T. Harju, R. Sormunen, E. Lappi-Blanco, J. Mäkinen, K. Laitakari, S. Johnson, R. Kaarteenaho (Oulu, Kuopio, Finland). Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Eur Respir J 2013; 42: Suppl. 57, 609
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013
Role of chronic exposure to cigarette smoke on endoglin/CD105 expression in airway epithelium
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Mucociliary function in bronchial epithelium of COPD and non-COPD patients: In vitro assessment of the effects of fluid restriction
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Acute cigarette smoke induces accelerated emphysema development in bENaC-overexpressed mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
A possible role of Krüppel-like factor 5 in small airway wall fibrosis in COPD
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Epithelial mesenchymal transition (EMT) in small and large airways of smokers; and relation to airflow obstruction
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Investigating large and small airway epithelial cell senescence in COPD and bronchiectasis
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Cigarette smoke impairs autophagic flux in bronchial epithelial cells
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept